BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15914298)

  • 1. The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy.
    Karch R; Neumann F; Ullrich R; Neumüller J; Podesser BK; Neumann M; Schreiner W
    Cardiovasc Pathol; 2005; 14(3):135-44. PubMed ID: 15914298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of remodeling of myocardial lymphatic and blood microvascular structures in terminal heart failure: differences between ischemic and dilated cardiomyopathy.
    Dashkevich A; Bloch W; Antonyan A; Goebel H; Fries JU; Schlensak C; Beyersdorf F; Geissler HJ
    Lymphology; 2010 Sep; 43(3):110-7. PubMed ID: 21226413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy.
    Noutsias M; Pauschinger M; Schultheiss H; K hl U
    Med Sci Monit; 2002 Jul; 8(7):CR478-87. PubMed ID: 12118194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy.
    Erbs S; Gielen S; Linke A; Möbius-Winkler S; Adams V; Baither Y; Schuler G; Hambrecht R
    Am Heart J; 2003 Aug; 146(2):280-5. PubMed ID: 12891196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods.
    Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Mazurkiewicz L; Skwarek M; Walczak E; Michalak E; Cedro K; Chmielak Z; Debski A; Demkow M; Witkowski A; Wagner T; Ruzyłło W
    Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM).
    Theiss HD; David R; Engelmann MG; Barth A; Schotten K; Naebauer M; Reichart B; Steinbeck G; Franz WM
    Eur Heart J; 2007 May; 28(10):1258-64. PubMed ID: 17395679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.
    Lionetti V; Matteucci M; Ribezzo M; Di Silvestre D; Brambilla F; Agostini S; Mauri P; Padeletti L; Pingitore A; Delsedime L; Rinaldi M; Recchia FA; Pucci A
    J Cell Mol Med; 2014 Mar; 18(3):396-414. PubMed ID: 24444256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
    Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB
    Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy.
    Tsagalou EP; Anastasiou-Nana M; Agapitos E; Gika A; Drakos SG; Terrovitis JV; Ntalianis A; Nanas JN
    J Am Coll Cardiol; 2008 Oct; 52(17):1391-8. PubMed ID: 18940529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Ca2+ sensitivity of myofibrillar tension in ischaemic vs dilated cardiomyopathy.
    Lee S; Lu R; Müller-Ehmsen J; Schwinger RH; Brixius K
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1134-8. PubMed ID: 20804510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy.
    Shmilovich H; Danon A; Binah O; Roth A; Chen G; Wexler D; Keren G; George J
    Int J Cardiol; 2007 Apr; 117(2):198-203. PubMed ID: 16887211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and functional determinants of coronary flow reserve in non-ischemic dilated cardiomyopathy: an echocardiographic study.
    Santagata P; Rigo F; Gherardi S; Pratali L; Drozdz J; Varga A; Picano E
    Int J Cardiol; 2005 Oct; 105(1):46-52. PubMed ID: 16207544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of echocardiographic findings in patients with coronary triple vessel disease and dilated cardiomyopathy].
    Nakamura H; Sawada H; Aizawa T; Watanabe H; Fujii J
    J Cardiogr; 1985 Sep; 15(3):585-93. PubMed ID: 3837056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications and results of orthotopic heart transplantation in coronary heart disease].
    Herrmann G; Haverich A; Cremer J; Fieguth HG; Jurmann M; Wahlers T; Borst HG
    Z Gesamte Inn Med; 1989 Jan; 44(1):6-11. PubMed ID: 2652897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial catecholamine content in heart failure--I: Regional distribution in explanted hearts. Comparison between dilated cardiomyopathy and coronary heart disease].
    Regitz V; Sasse S; Bossaller C; Strasser R; Schüler S; Hetzer R; Fleck E
    Z Kardiol; 1989 Dec; 78(12):751-8. PubMed ID: 2623916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy.
    Abraham D; Hofbauer R; Schäfer R; Blumer R; Paulus P; Miksovsky A; Traxler H; Kocher A; Aharinejad S
    Circ Res; 2000 Oct; 87(8):644-7. PubMed ID: 11029398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy.
    Herpel E; Pritsch M; Koch A; Dengler TJ; Schirmacher P; Schnabel PA
    Histopathology; 2006 May; 48(6):736-47. PubMed ID: 16681691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy.
    Athanassopoulos P; Balk AH; Vaessen LM; Caliskan K; Takkenberg JJ; Weimar W; Bogers AJ
    Int J Cardiol; 2009 Jan; 131(2):246-56. PubMed ID: 18243370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.